Despite the evidence that smoking is one of the main predictors of the cardiovascular disease risk among hypertensive subjects, there are very few data available of the smoking trends of these subjects at public health level. This study assesses the trends in smoking and in smoking cessation advice given by physicians in the hypertensive and normotensive population in 
Introduction
The risk of coronary heart disease and stroke for hypertensive subjects depends highly on the levels of other major cardiovascular risk factors. 1 Many follow-up studies have determined that the total cardiovascular risk in hypertensive patients who smoke is manyfold compared to their non-smoking counterparts. 2 In addition to its well-known effect on provoking atherosclerosis and thrombosis, as well as interfering with the efficacy of some antihypertensive agents, smoking increases the cardiovascular risk by affecting the lipid levels in a deleterious way. [3] [4] [5] Despite the fact that smoking cessation is the most powerful single act to reduce cardiovascular risk in a hypertensive patient, relatively little attention is paid to tobacco addiction by ber of participants was 24 083. In men, the prevalence of smoking decreased significantly in both treated hypertensive patients and normotensive subjects during 1982-1997, whereas it increased significantly in treated hypertensive women. The proportion of current smokers who had been advised to stop smoking by their physician was significantly higher in treated hypertensive men compared to the other subgroups of men (P Ͻ 0.001). The observed decreasing trend in smoking in men is encouraging, but the increase in smoking among hypertensive women taking antihypertensive medication warrants concern. In the future, the methods used for smoking cessation advice given by health care personnel should be intensified to make this effort more effective Journal of Human Hypertension (2002) 16, 299-303. DOI: 10.1038/sj/jhh/1001322 the health professionals who have responsibility for care of this patient group. Moreover, notwithstanding its public health importance, there is virtually no data available on secular trends in smoking in hypertensive subjects at the population level.
The multinational MONICA (monitoring trends and determinants in cardiovascular diseases) study was initiated by World Health Organization (WHO) in 1982. 6 The FINMONICA study was the Finnish part of this project acting as a continuation of the population surveys initiated in the North Karelia Project since 1972. The FINMONICA surveys were organised within this same framework in 1982, 1987 and 1992. The subsequent comparable survey (the FINRISK study) to assess national risk factor trends was organised in 1997. Our previous article indicated that prevalence of smoking remained essentially unchanged from 1982 to 1987 in hypertensive subjects participating in the study. 7 In this paper we will describe the trends in prevalence of smoking and in health counselling targeted for smoking cessation in three sub-groups of Finnish hypertensive
Materials and methods
Four independent cross-sectional population surveys were carried out in 1982, 1987, 1992 and in 1997 in the provinces of North Karelia and Kuopio in eastern Finland and in Turku-Loimaa region in south-western Finland. In each survey the field work was started in January and was completed in April. Random samples aged 25-64 years were chosen each year from the national population register. In 1982, the sample was stratified so that 500 persons for each sex and 10-year age group were chosen from the areas. In 1987, the procedure was similar but the number of subjects in Kuopio and Turku-Loimaa region was halved. In 1992 and 1997, the number was halved also in North Karelia province so that the samples were of equal size in each area. For the purposes of this article, all three study areas were pooled together. The total number of respondents in the four surveys combined was 24 083, with participation rates varying from 69% to 73% in men and from 76% to 82% in women (the percentage of participants with complete data for the blood pressure status classification to the number of all subjects invited to the study), as shown in Table 1 .
The survey methods were carefully standardised and followed the WHO MONICA protocol. 8 Information on the awareness of hypertension, use of antihypertensive drugs and smoking were obtained with a standardised, self-administered questionnaire. Blood pressure (BP) was measured twice by the specially trained nurses from the right arm of the subject, who was seated for 5 min before the measurement. A standard mercury sphygmomanometer with a cuff bladder 13 cm wide and 42 cm long was used. The fifth phase of the Korotkoff sounds was used as the diastolic BP, and the values were recorded to the nearest 2 mm Hg. The mean of these two measurements was used in the analyses. A person was considered to have hypertension when the average BP was at least 160 mm Hg systolic or 95 mm Hg diastolic or if he or she reported having taken antihypertensive drugs during the preceding 7 days. The study population was classified into four groups according to their BP status: unaware and untreated hypertensive subjects, aware but untreated hypertensive subjects, hypertensive patients treated with antihypertensive drugs and normotensive subjects. Smoking was assessed by using a standard set of questions in each survey. Based on the responses, the participants were classified into three smoking categories: (I) current smokers (those who had smoked regularly cigarettes, cigars or pipe for at least 1 year and had been smoking during the preceding month); (II) ex-smokers (those who had smoked regularly in the past but had stopped smoking no later than a month before the survey); and (III) never smokers (those who had never smoked regularly). The ex-smokers having quit just during the past month were excluded from the analyses. The smokers were asked if they were willing to break the habit and if they had tried to quit smoking. They were also asked if they had been advised to stop smoking by a physician during the preceding year.
Statistical analyses were conducted with the SPSS for Windows version 8.0. Differences between the proportions were assessed by hierarchical log-linear model with survey year, BP group and 10-year agegroup together with the variable to be tested in the model. Confidence intervals for the change in proportions for each gender and BP group separately were calculated using a special software package. 9 
Results
The proportion of current smokers decreased significantly in normotensive men and especially in treated hypertensive men during 1982-1997 (Table 2 ). This proportion remained essentially unchanged in other male BP groups. In 1997, smoking was least common in treated hypertensive men in whom only one in every five was a current smoker, whereas in the other BP groups the corresponding proportion was approximately one in three. In normotensive women, the proportion of smokers remained stable during the study period. In contrast, the prevalence of smoking tended to increase in every subgroup of hypertensive women, this increase even being statistically significant only in subjects taking antihypertensive medication (interaction between smoking category, survey year and BP group, P = 0.032). In the last survey, the percentage of smokers in drug-treated women was 12%. This proportion varied between 17% and 20% in the other BP groups. In men, the proportion of ex-smokers remained unchanged in every BP group. Throughout the period of observation, history of smoking cessation was most frequent in men treated with antihypertensive drugs. In contrast to men, the proportion of women who had stopped smoking increased significantly in normotensive women and also in aware but untreated hypertensive women. In the last survey, smoking cessation had occurred most frequently in normotensive women.
The proportion of never smokers in men increased significantly in the normotensive group and in aware but untreated hypertensive subjects. The
Journal of Human Hypertension increase was also almost significant in treated hypertensive patients. In women, this proportion decreased significantly in all BP groups except in unaware and untreated subjects.
The proportion of current smokers who had tried to stop smoking during the past year remained rather stable in all male BP groups (Table 3 ). In women, the corresponding proportion tended to decrease in all BP groups (interaction between attempt to quit and survey year, P = 0.004). Within the separate subgroups, the decrease was significant only in aware but untreated hypertensive subjects. In both sexes, no significant changes were observed in the proportion of smokers willing to stop smoking during the observation period (data not shown). In men, the willingness to quit was most common in treated hypertensive patients (65% of smokers) and least common in aware but untreated hypertensive subjects (48% of smokers) in the last survey. In women, 58% of smokers were willing to quit in both the normotensive group and in the drug-treated hypertensive group, whereas only 46% of aware but untreated hypertensive smokers wanted to break their habit. The proportion of male smokers who reported that they had received advice from their physician to stop smoking during the preceding year remained unchanged in every BP group during 1982-1997 (Table 4) . In each survey, this proportion was highest in treated hypertensive men (interaction between received advice and BP group, P Ͻ 0.001). In 1997, 63% of drug-treated hypertensive men had received this advice which was more than twice that in the normotensive group. In female smokers, the corresponding proportion showed an increasing trend in every BP group, although the increase was significant only in normotensive women. This proportion was highest in each survey until 1997 in treated hypertensive women. In the last survey, the proportion was highest, 55%, in the aware but untreated hypertensive group.
Discussion
The results of the present study showed a significant downward trend in prevalence of smoking in normotensive men as well as in drug-treated hypertensive men during 1982-1997. An increasing trend in the proportion of smokers was observed in all female BP groups, but the change was significant only in the drug-treated hypertensive group. Despite the fact that the majority of current smokers were willing to break their habit, the proportion of current smokers having recently tried to quit smoking remained low. There were no significant differences in this respect between the BP categories of either sex. The proportion of current smokers who had been advised to quit by their doctor during the last year increased slightly but significantly in normotensive women, but not in any other female or male BP group.
In Finland, the prevalence of smoking in both men and women in nowadays among the lowest in Europe. Since the early 1960s, the proportion of smokers has decreased by one half in men. Among women, smoking was fairly rare until the 1970s, but since then a significant increase has occurred. During 1972-1982, the decrease in smoking prevalence in men was mainly explained by the increased smoking cessation, but since 1982 the decrease in the numbers starting to smoke has been the main reason for the continuing trend. 10 The contributing factors for the observed decrease in smoking include several preventive activities targeted against smoking, as well as the passing of the first tobacco control legislation in 1977, which was updated in 1995. In women, the observed increase in smoking prevalence among the middle-aged women was mainly due to an augmented rate of smoking initiation among young women in the 1960s and the 1970s suggesting a cohort effect. Since then the initiation rate among the youngest age-groups has remained rather stable. In contrast to men, smoking cessation has increased steadily among women also since 1982, though not sufficient to prevent the moderate upward trend in female smoking.
According to many prospective studies, continued smoking is one of the main determinants for excess mortality among treated hypertensive subjects. 11, 12 Therefore, the activities targeting for smoking cessation are of major importance especially with this patient-group. In our study, the fact that the proportion of ex-smokers remained rather stable also in this BP group indicates that the decrease in smoking prevalence was mainly due to decreased smoking initiation. In these subjects, also the proportion of exsmokers was significantly greater throughout the study period compared with other BP groups. In contrast to these positive findings, the fact that the proportion of smokers remained unchanged and was of the same magnitude in the two untreated hypertensive groups as in the normotensive subjects in 1997 was alarming. In women, the observed increase in smoking in the drug-treated hypertensive group was mainly caused by an increased initiation rate.
Advice targeting for smoking cessation is one of the cornerstones in the treatment of hypertension as recommended by the most recent international hypertension guidelines. [13] [14] [15] According to our study, the proportion of current smokers being recently advised by their physician to quit was significantly greater in the drug-treated hypertensive men compared with three other male BP groups. In women, the situation was somewhat similar until 1997, when the proportion of smokers who had been recently encouraged to quit increased in the two untreated hypertensive groups to the same level as in the drug-treated group. Despite this observed difference in health counselling between the BP groups, there were no differences between the groups in self-reported attempts to quit smoking among the current smokers. Paradoxically, at the same time with the significant increase in the proportion of normotensive smoking women being advised to quit during 1982-1997, the rate of quitting attempts tended to decrease. In both genders, the small number of ex-smokers who had managed to quit smoking during the preceding year did not allow us to make any comparison between them and current smokers in terms of provision of anti-smoking advice.
Brief but regular advice, nicotine replacement therapy and treatment by some antidepressants are the strategies used in clinical trials that have proven their efficacy and safety in smoking cessation. [16] [17] [18] [19] In the future, to increase the efficacy of advice offered by physicians against smoking, these strategies should be used more routinely as a part of multifactorial cardiovascular risk approach in the treatment of hypertensive patients. One barrier for achieving this goal is the somewhat limited knowledge among physicians on how to implement these strategies in practice. One of the key elements to overcome this barrier in the future could be the creation of national smoking cessation guidelines such as those already developed for the treatment of hypertension and dissemination of these guidelines to all practicing physicians. More routine involvement of nurses in anti-smoking counselling in cooperation with physicians could also represent one solution to this problem. 20 In conclusion, the observed decreasing trend in smoking in Finnish men is encouraging, but the increase in smoking among hypertensive women with antihypertensive medication warrants concern. In the future, the methods used for anti-smoking advice given by health care personnel should be optimised to make this advice more effective, particularly in people with high risk of cardiovascular disease such as those with hypertension.
